{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:36:05Z","timestamp":1773286565622,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.vaccine.2007.12.015","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T15:34:34Z","timestamp":1199720074000},"page":"882-890","source":"Crossref","is-referenced-by-count":28,"title":["Evaluation of the Langat\/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers"],"prefix":"10.1016","volume":"26","author":[{"given":"Peter F.","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Ankrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna P.","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Speicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen S.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander G.","family":"Pletnev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.12.015_bib1","series-title":"Fields virology","first-page":"196","article-title":"Flaviviruses","author":"Monath","year":"1996"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2007.12.015_bib2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0264-410X(02)00812-5","article-title":"Epidemiology and ecology of TBE relevant to the production of effective vaccines","volume":"21","author":"Suss","year":"2003","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2007.12.015_bib3","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.015_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s15010-006-6614-2","article-title":"Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination","volume":"35","author":"Kleiter","year":"2007","journal-title":"Infection"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2007.12.015_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1099\/0022-1317-75-1-227","article-title":"Analysis of the structural protein gene sequence shows Kyasanur Forest disease virus as a distinct member in the tick-borne encephalitis virus serocomplex","volume":"75","author":"Venugopal","year":"1994","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.015_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/viro.1993.1247","article-title":"Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses","volume":"194","author":"Mandl","year":"1993","journal-title":"Virology"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2007.12.015_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1099\/0022-1317-74-2-287","article-title":"Nucleotide and deduced amino acid sequence of the envelope glycoprotein of Omsk haemorrhagic fever virus; comparison with other flaviviruses","volume":"74","author":"Gritsun","year":"1993","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.015_bib8","first-page":"89","article-title":"Vaccination of human volunteers against Russian spring-summer (RSS) virus complex with attenuated Langat E5 virus","volume":"42","author":"Price","year":"1970","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.015_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4269\/ajtmh.1973.22.100","article-title":"Immunization of mice against Russian spring-summer virus complex and monkeys against Powassan virus with attenuated Langat E5 virus. Duration of protection","volume":"22","author":"Price","year":"1973","journal-title":"Am J Trop Med Hyg"},{"issue":"17","key":"10.1016\/j.vaccine.2007.12.015_bib10","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1128\/JVI.75.17.8259-8267.2001","article-title":"Tick-borne Langat\/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes","volume":"75","author":"Pletnev","year":"2001","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.12.015_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-3542(02)00206-1","article-title":"Tick-borne encephalitis","volume":"57","author":"Gritsun","year":"2003","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.vaccine.2007.12.015_bib12","first-page":"229","article-title":"A live vaccine against tick-born encephalitis: integrated studies. III. Response of man to a single dose of the E5 \u201c14\u201d clone (Langat virus)","volume":"19","author":"Mayer","year":"1975","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2007.12.015_bib13","series-title":"Tick-borne encephalitis and its vaccine prophylaxis","first-page":"190","article-title":"Live vaccines against tick-borne encephalitis","author":"Smorodincev","year":"1986"},{"key":"10.1016\/j.vaccine.2007.12.015_bib14","first-page":"133","article-title":"Study of the distant consequences of immunizing people with a live vaccine against tick-borne encephalitis","volume":"65","author":"Shapoval","year":"1989","journal-title":"Tr Inst Im Pastera"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2007.12.015_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0020-7519(03)00063-8","article-title":"Traditional and novel approaches to flavivirus vaccines","volume":"33","author":"Pugachev","year":"2003","journal-title":"Int J Parasitol"},{"issue":"21","key":"10.1016\/j.vaccine.2007.12.015_bib16","doi-asserted-by":"crossref","first-page":"10532","DOI":"10.1073\/pnas.89.21.10532","article-title":"Construction and characterization of chimeric tick-borne encephalitis\/dengue type 4 viruses","volume":"89","author":"Pletnev","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2007.12.015_bib17","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1128\/JVI.67.8.4956-4963.1993","article-title":"Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice","volume":"67","author":"Pletnev","year":"1993","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.12.015_bib18","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1073\/pnas.95.4.1746","article-title":"Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4","volume":"95","author":"Pletnev","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.015_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/viro.2000.0426","article-title":"Chimeric Langat\/dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus","volume":"274","author":"Pletnev","year":"2000","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2007.12.015_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2005.07.067","article-title":"Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys","volume":"24","author":"Rumyantsev","year":"2006","journal-title":"Vaccine"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2007.12.015_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/0022-1317-80-1-179","article-title":"Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia","volume":"80","author":"Ecker","year":"1999","journal-title":"J Gen Virol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.12.015_bib22","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.12.015_bib23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/14760584.4.5.747","article-title":"Tick-borne encephalitis vaccines: past and present","volume":"4","author":"Zent","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2007.12.015_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00415-004-0329-z","article-title":"Two severe cases of tick-borne encephalitis despite complete active vaccination\u2013the significance of neutralizing antibodies","volume":"251","author":"Bender","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.vaccine.2007.12.015_bib25","series-title":"Vaccines","first-page":"1095","article-title":"Yellow fever vaccine","author":"Monath","year":"2004"},{"key":"10.1016\/j.vaccine.2007.12.015_bib26","series-title":"Vaccines","first-page":"919","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2004"},{"issue":"3","key":"10.1016\/j.vaccine.2007.12.015_bib27","first-page":"425","article-title":"Experience in the study of a live vaccine made from the TP-21 strain of Malayan Langat virus","volume":"39","author":"Il\u2019enko","year":"1968","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.vaccine.2007.12.015_bib28","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J Virol"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2007.12.015_bib29","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","volume":"17","author":"Monath","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.015_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1743-422X-4-23","article-title":"Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1","volume":"4","author":"Blaney","year":"2007","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.015_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.virol.2007.04.016","article-title":"JE Nakayama\/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease","volume":"366","author":"Chambers","year":"2007","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2007.12.015_bib32","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/427780","article-title":"rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers","volume":"191","author":"Durbin","year":"2005","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2007.12.015_bib33","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"Monath","year":"2003","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.015_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.12.015_bib35","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0042-6822(91)90567-U","article-title":"Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev","volume":"185","author":"Mandl","year":"1991","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2007.12.015_bib36","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1128\/JVI.79.9.5516-5528.2005","article-title":"Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys","volume":"79","author":"Blaney","year":"2005","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0701479X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0701479X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T12:52:01Z","timestamp":1588251121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0701479X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0264410X0701479X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.12.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}